CR4-HM1N122-100μg / 询价
CR4-HM1N122-100μg x 5 / 询价
CR4-HM1N122-100μg x 10 / 询价
- 客服电话
- 技术支持
FITC-equivalent Human CCR4 Protein-Nanodisc
Recombinant FITC-equivalent Human CCR4 Protein-Nanodisc is expressed from HEK293 with His tag at the C-terminus.It contains Met1-Leu360 [Accession | P51679].
The protein has a predicted MW of 69.20 kDa.
Excitation Wavelength: 490 nm
Emission Wavelength: 520 nm
Less than 1EU per μg by the LAL method.
Supplied as 0.22 μm filtered solution in PBS (pH 7.4). Notice: Not recommended for immunization.
Valid for 12 months from date of receipt when stored at -80°C.
Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Immobilized FITC-equivalent Human CCR4 Nanodisc, His Tag at 2μg/ml (100μl/well) on the plate. Dose response curve for Anti-CCR4 Antibody, hFc Tag with the EC50 of 12.6ng/ml determined by ELISA (QC Test).
CC chemokine receptor 4 (CCR4) is a chemokine receptor mainly expressed by T cells. CCR4 is important in the pathogenesis of many diseases, such as diabetes, multiple sclerosis, asthma, dermatitis, and cancer. This review briefly characterizes CCR4 and its ligands (CCL17, CCL22, and CCL2), and their contributions to immunological and neoplastic diseases.
C-C CKR-4; CC-CKR-4; CCR-4; CCR4; K5-5; CD194; CMKBR4; CKR-4
(1) Yoshie O. CCR4 as a Therapeutic Target for Cancer Immunotherapy. Cancers (Basel). 2021 Nov 4;13(21):5542. doi: 10.3390/cancers13215542. PMID: 34771703; PMCID: PMC8583476.
(2) Bogacka J, Pawlik K, Ciapała K, Ciechanowska A, Mika J. CC Chemokine Receptor 4 (CCR4) as a Possible New Target for Therapy. Int J Mol Sci. 2022 Dec 9;23(24):15638. doi: 10.3390/ijms232415638. PMID: 36555280; PMCID: PMC9779674.
